COVID-19 and liver disease: Are we missing something?
World J Hepatol
; 14(2): 479-481, 2022 Feb 27.
Article
in English
| MEDLINE | ID: covidwho-1726439
ABSTRACT
Since the coronavirus disease 2019 (COVID-19) has hit the world as a pandemic, researchers all over the world have worked on its diagnostics, prognosticating factors, etc. The present study showed liver enzymes, especially aspartate aminotransferase (AST) levels, to be high in non-survivors with raised AST/alanine aminotransferase ratio. Considering the non-specific nature of AST with its presence in organs other than liver such as muscle, heart, kidney and brain makes it difficult to interpret. Even pre-existing metabolic syndrome and non-alcoholic fatty liver disease are confounding factors for deranged liver functions detected during COVID-19 disease. Therefore, the results of the study should be taken with caution.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Prognostic study
Language:
English
Journal:
World J Hepatol
Year:
2022
Document Type:
Article
Affiliation country:
Wjh.v14.i2.479
Similar
MEDLINE
...
LILACS
LIS